🇺🇸 FDA
Patent

US 11925686

Materials for phototherapies of ophthalmic diseases

granted A61KA61K41/0057A61K41/0071

Quick answer

US patent 11925686 (Materials for phototherapies of ophthalmic diseases) held by EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD. expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
Grant date
Tue Mar 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K41/0057, A61K41/0071, A61K41/0076, A61K47/58